Stockscreener 앱 받기
4.06
2.27%
0.09
시간 외 거래:
4.24
0.18
+4.43%
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INOVIO Set to Unveil Q3 2024 Financial Results and Business Insights on November 14! - MSN
July 25, 2024 - Site Selection Magazine
What is HC Wainwright's Estimate for INO FY2024 Earnings? - MarketBeat
Inovio Pharmaceuticals (LTS:0A43) Debt-to-Equity : 0.13 (As of Jun. 2024) - GuruFocus.com
Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
INOVIO Reports Third-Quarter Financial Results and Updates on INO-3107 Progress - MyChesCo
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals - Benzinga
Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $5.00 by Analysts at HC Wainwright - MarketBeat
INOVIO Announces Promising Immunology Data for INO-3107 in RRP Treatment - MyChesCo
Inovio stock hits 52-week low at $4.15 amid market challenges - Investing.com Nigeria
Inovio Pharmaceuticals (NASDAQ:INO) Given New $15.00 Price Target at Oppenheimer - MarketBeat
Inovio shares target cut by Oppenheimer, retains outperform on Q3 results - Investing.com UK
Inovio Pharma Stock Slips Ahead of Q3 Earnings: Retail’s Bullish - MSN
Inovio focused on launching global COVID-19 vaccine trial next month - The Jerusalem Post
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) - Yahoo Finance
Inovio to begin mid-stage study of COVID-19 vaccine candidate - Reuters
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Royal Bank of Canada Cuts Inovio Pharmaceuticals (NASDAQ:INO) Price Target to $6.00 - MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2024 Earnings Call Transcript - Insider Monkey
Inovio: Q3 Earnings Snapshot - mySA
Q3 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus.com
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... - Yahoo Finance
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript - Barchart
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
INOVIO Reports Third Quarter 2024 Financial Results and Recent B - GuruFocus.com
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... By GuruFocus - Investing.com Canada
INO-3107 shows promise in reducing surgeries for RRP patients By Investing.com - Investing.com Australia
Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail
A Preview Of Inovio Pharmaceuticals's Earnings - Benzinga
Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR
INO-3107 shows promise in reducing surgeries for RRP patients - Investing.com India
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - Yahoo Finance
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals (INO) Set to Announce Earnings on Thursday - MarketBeat
Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch
INOVIO to Present at Upcoming Scientific Conferences - Marketscreener.com
INOVIO to Present Breakthrough DNA Vaccine Research at Two Major Scientific Conferences | INO Stock News - StockTitan
INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 - Marketscreener.com
INOVIO to Report Q3 2024 Financial Results on Nov 14 - Chicago Star Media
INOVIO (INO) Sets Q3 2024 Earnings Call: DNA Medicine Updates Expected | INO Stock News - StockTitan
Algoma Central (ALC-T) QuotePress Release - The Globe and Mail
INO (Inovio Pharmaceuticals) Ending Cash Position : $34.39 Mil (As of Jun. 2024) - GuruFocus.com
Inovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms market - MarketWatch
Inovio Pharmaceuticals (LTS:0A43) Probability of Financial Distress (%) : 0.27% (As of Oct. 30, 2024) - GuruFocus.com
0.93%
3.55%
자본화:
|
볼륨(24시간):